TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
CRLBF

Cresco Labs Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

0.6445$ +0.7% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Cresco Labs Inc. (CRLBF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,263 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRLBF
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,399 1,358 1,360 1,358 1,383 1,355 1,364 1,348 1,280 1,197 1,199 1,263
303 278 285 273 312 294 311 315 243 259 247 246
107 103 123 112 153 138 155 147 45 58 32 33
57 51 50 54 55 52 45 39 43 38 38 40
115 108 98 95 92 83 87 89 93 99 108 111
280 280 280 283 284 283 283 283 283 208 209 222
298 297 298 300 296 294 293 289 292 275 288 321
973 930 940 984 1,018 967 989 987 940 945 955 1,000
261 200 209 137 159 94 113 101 97 100 98 138
20 28 17 19 19 14 18 17 17 17 14 16
491 498 498 499 499 461 371 372 327 417 418 420
506 506 503 468 457 475 462 444 428 340 336 359
-1,271 -1,266 -1,274 -1,336 -1,346 -1,352 -1,369 -1,390 -1,409 -1,500 -1,516 -1,499
338 340 342 348 348 349 353 355 357 360 370 372

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?